BridgeMD
New treatment option for Dementia, Vascular
Official title Home Tele Rehabilitation Therapy for Vascular Dementia
ClinicalTrials.gov ID: NCT06289569
What this study is testing
- What it's testing
- To determine whether the home telerehabilitation therapy is feasible and lessens caregiver burden in chronic stroke patients with and without vascular dementia (VaD)
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 110
You may be able to join if
- Symptomatic ischemic or hemorrhagic stroke verified by computerized axial tomography or magnetic resonance imaging
- at least 6 months post stroke
- At least some active movement in the affected upper extremity (MRS 1 or more in shoulder elbow or wrist)
- Ability to provide informed consent, or LAR able to provide consent
- Expressed willingness to comply with all study procedures and attend all study-related visits for both the patient and at least one caregiver.
You likely can't join if
- Patients with history of severe alcohol or drug abuse, psychiatric illnesses like severe depression, poor motivational capacity, or severe language...
- Patients with bilateral paresis, or weakness or sensory damage due to peripheral causes (e.g. peripheral nerve injury, muscle or orthopedic injury...
- Patients with severe uncontrolled medical problems that would render intensive rehabilitation unfeasible or unsafe (e.g. cardiovascular disease...
- Concurrent participation in other experimental upper extremity rehabilitation trials that would interfere with results.
- Non-English-speaking individuals will only be eligible if they can provide the appropriate translator for all the sessions of the study as no funding...
- Pregnancy
See the full eligibility criteria
- Symptomatic ischemic or hemorrhagic stroke verified by computerized axial tomography or magnetic resonance imaging
- at least 6 months post stroke
- At least some active movement in the affected upper extremity (MRS 1 or more in shoulder elbow or wrist)
- Ability to provide informed consent, or LAR able to provide consent
- Expressed willingness to comply with all study procedures and attend all study-related visits for both the patient and at least one caregiver.
- Age ≥ 18.
- Ability to follow one-step commands.
- Community-dwelling with transportation to evaluation sessions.
- Ability to operate the therapy system with minimal assistance, including sufficient corrected vision to perceive objects from a distance of 5 feet.
- Modified Ashworth Scale Score 3 or less in the involved upper extremity
- Passive range of motion within functional ranges at the shoulder, elbow, wrist and hand
- Patients with history of severe alcohol or drug abuse, psychiatric illnesses like severe depression, poor motivational capacity, or severe language disturbances, particularly of receptive nature or with serious...
- Patients with bilateral paresis, or weakness or sensory damage due to peripheral causes (e.g. peripheral nerve injury, muscle or orthopedic injury etc.)
- Patients with severe uncontrolled medical problems that would render intensive rehabilitation unfeasible or unsafe (e.g. cardiovascular disease, unstable cardiac arrhythmia, severe rheumatoid arthritis, active joint...
- Concurrent participation in other experimental upper extremity rehabilitation trials that would interfere with results.
- Non-English-speaking individuals will only be eligible if they can provide the appropriate translator for all the sessions of the study as no funding is available to pay for such services. However, we plan to include...
- Pregnancy
- Prisoners
The study team makes the final eligibility decision.
Where it's taking place
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 110 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.